Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NOVOEIGHT safely and effectively. See full prescribing information for NOVOEIGHT.NOVOEIGHT (antihemophilic factor, recombinant)lyophilized powder for solution, for intravenous use Initial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-other
Novoeight, Antihemophilic Factor (Recombinant), is a human antihemophilic factor (human blood coagulation factor VIII (FVIII)) indicated for use in adults and children with hemophilia A for: •On-demand treatment and control of bleeding episodes •Perioperative management •Routine prophylaxis to reduce the frequency of bleeding episodes Novoeight is not indicated for the treatment of von Willebrand disease.
- generic_name
- antihemophilic factor recombinant
- brand_name
- Sodium chloride solution
- product_names
- antihemophilic factor recombinant, Sodium chloride solution
- ndc
- 0169-7825, 0169-7825-01, 0169-7829, 0169-7829-11, 0169-7008, 0169-7008-98, 0169-7850, 0169-7850-01, 0169-7851, 0169-7851-11, 0169-7810, 0169-7810-01, 0169-7811, 0169-7811-11, 0169-7815, 0169-7815-01, 0169-7855, 0169-7855-11, 0169-7820, 0169-7820-01, 0169-7821, 0169-7821-11, 0169-7830, 0169-7830-01, 0169-7831, 0169-7831-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en